N064-0029 Screening compound: 5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-3a-[(pyridine-4-carbonyloxy)methyl]-icosahydro-1H-cyclopenta[a]chrysen-9-yl pyridine-4-carboxylate

N064-0029 Screening compound: 5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-3a-[(pyridine-4-carbonyloxy)methyl]-icosahydro-1H-cyclopenta[a]chrysen-9-yl pyridine-4-carboxylate
N064-0029 Screening compound: 5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-3a-[(pyridine-4-carbonyloxy)methyl]-icosahydro-1H-cyclopenta[a]chrysen-9-yl pyridine-4-carboxylate alternative view

Chemical Structure Depiction of ChemDiv screening compound N064-0029
5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-3a-[(pyridine-4-carbonyloxy)methyl]-icosahydro-1H-cyclopenta[a]chrysen-9-yl pyridine-4-carboxylate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

N064-0029

Molecular Formula

C42H56N2O4 (C42 H56 N2 O4)

Compound Name

5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-3a-[(pyridine-4-carbonyloxy)methyl]-icosahydro-1H-cyclopenta[a]chrysen-9-yl pyridine-4-carboxylate

IUPAC name

(1R5aR5bR11aR)-5a5b8811a-pentamethyl-1-(prop-1-en-2-yl)-3a-[(pyridine-4-carbonyloxy)methyl]-icosahydro-1H-cyclopenta[a]chrysen-9-yl pyridine-4-carboxylate

SMILES

CC(C)(C(CC1)[C@@](C)(CC2)C(CC3)[C@@]1(C)[C@]1(C)C3C([C@H](CC3)C(C)=C)C3(COC(c3ccncc3)=O)CC1)C2OC(c1ccncc1)=O

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

652.92

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

8.498

Distribution Coefficient, logD

8.498

Water Solubility, LogSw

-5.99

Polar Surface Area

60.028

Acid Dissociation Constant (pKa)

27.90

Base Dissociation Constant (pKb)

4.55

Number of Chiral Centers

10.00

Percent sp3 carbon bonding

66.70

N064-0029 in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CORONAVIRUS Library (20774 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Steroid-like Compounds (494 compounds)

Natural Compounds Library (353 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cardiovascular
  • Metabolic
  • Immune system
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Structure:
  • Cyclic compounds
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with N064-0029 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound N064-0029?
Check Price and Availability of N064-0029, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of N064-0029 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for N064-0029
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for N064-0029
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of N064-0029 available by request